These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
42. The enhanced tumorigenic activity of a mutant epidermal growth factor receptor common in human cancers is mediated by threshold levels of constitutive tyrosine phosphorylation and unattenuated signaling. Huang HS; Nagane M; Klingbeil CK; Lin H; Nishikawa R; Ji XD; Huang CM; Gill GN; Wiley HS; Cavenee WK J Biol Chem; 1997 Jan; 272(5):2927-35. PubMed ID: 9006938 [TBL] [Abstract][Full Text] [Related]
43. A single amino acid exchange, Arg-45 to Ala, generates an epidermal growth factor (EGF) mutant with high affinity for the chicken EGF receptor. van de Poll ML; Lenferink AE; van Vugt MJ; Jacobs JJ; Janssen JW; Joldersma M; van Zoelen EJ J Biol Chem; 1995 Sep; 270(38):22337-43. PubMed ID: 7673217 [TBL] [Abstract][Full Text] [Related]
44. A fusion plasmid for the synthesis of lipopeptide-antigen chimeras in Escherichia coli. Rioux CR; Bergeron H; Lin L; Grothe S; O'Connor-McCourt M; Lau PC Gene; 1992 Jul; 116(1):13-20. PubMed ID: 1628839 [TBL] [Abstract][Full Text] [Related]
45. Heparin stimulates epidermal growth factor receptor-mediated phosphorylation of tyrosine and threonine residues. Revis-Gupta S; Abdel-Ghany M; Koland J; Racker E Proc Natl Acad Sci U S A; 1991 Jul; 88(14):5954-8. PubMed ID: 1712476 [TBL] [Abstract][Full Text] [Related]
46. Deletion-mutant epidermal growth factor receptor in human gliomas: effects of type II mutation on receptor function. Humphrey PA; Gangarosa LM; Wong AJ; Archer GE; Lund-Johansen M; Bjerkvig R; Laerum OD; Friedman HS; Bigner DD Biochem Biophys Res Commun; 1991 Aug; 178(3):1413-20. PubMed ID: 1678600 [TBL] [Abstract][Full Text] [Related]
47. Identification of Treponema pallidum subspecies pallidum genes encoding signal peptides and membrane-spanning sequences using a novel alkaline phosphatase expression vector. Blanco DR; Giladi M; Champion CI; Haake DA; Chikami GK; Miller JN; Lovett MA Mol Microbiol; 1991 Oct; 5(10):2405-15. PubMed ID: 1791755 [TBL] [Abstract][Full Text] [Related]
48. Construction of secretory expression system suitable to express glucagon under the control of PL promoter. Wen C; Gan R; Zhu S Curr Microbiol; 2003 Sep; 47(3):180-5. PubMed ID: 14570266 [TBL] [Abstract][Full Text] [Related]
50. Production of glycosylated heparin-binding EGF-like growth factor in HeLa cells using vaccinia virus. Davis KM; Brigstock DR; Johnson PR; Crissman-Combs MA; McCarthy DW; Downing MT; Besner GE Protein Expr Purif; 1996 Aug; 8(1):57-67. PubMed ID: 8812835 [TBL] [Abstract][Full Text] [Related]
51. Structure-function analysis of a conserved aromatic cluster in the N-terminal domain of human epidermal growth factor. Murray MB; Tadaki DK; Campion SR; Lamerdin JA; Serpersu EH; Bradrick TD; Niyogi SK Protein Eng; 1998 Nov; 11(11):1041-50. PubMed ID: 9876925 [TBL] [Abstract][Full Text] [Related]
53. Characterization of the secretion efficiency of a plant signal peptide in Bacillus subtilis. Ribbe J; Nagarajan V Mol Gen Genet; 1992 Nov; 235(2-3):333-9. PubMed ID: 1465106 [TBL] [Abstract][Full Text] [Related]
54. Mutational removal of the Thr669 and Ser671 phosphorylation sites alters substrate specificity and ligand-induced internalization of the epidermal growth factor receptor. Heisermann GJ; Wiley HS; Walsh BJ; Ingraham HA; Fiol CJ; Gill GN J Biol Chem; 1990 Aug; 265(22):12820-7. PubMed ID: 2115882 [TBL] [Abstract][Full Text] [Related]
55. Structure-function relationships in human epidermal growth factor studied by site-directed mutagenesis and 1H NMR. Hommel U; Dudgeon TJ; Fallon A; Edwards RM; Campbell ID Biochemistry; 1991 Sep; 30(36):8891-8. PubMed ID: 1909576 [TBL] [Abstract][Full Text] [Related]
56. Tyrosine 67 in the epidermal growth factor-like domain of tissue-type plasminogen activator is important for clearance by a specific hepatic receptor. Bassel-Duby R; Jiang NY; Bittick T; Madison E; McGookey D; Orth K; Shohet R; Sambrook J; Gething MJ J Biol Chem; 1992 May; 267(14):9668-77. PubMed ID: 1315765 [TBL] [Abstract][Full Text] [Related]
57. [Epidermal growth factor and its receptor: the structure and function]. Gamou S; Shimizu N Nihon Rinsho; 1992 Aug; 50(8):1885-92. PubMed ID: 1433980 [TBL] [Abstract][Full Text] [Related]
58. Genetic engineering of snake toxins. Role of invariant residues in the structural and functional properties of a curaremimetic toxin, as probed by site-directed mutagenesis. Pillet L; Trémeau O; Ducancel F; Drevet P; Zinn-Justin S; Pinkasfeld S; Boulain JC; Ménez A J Biol Chem; 1993 Jan; 268(2):909-16. PubMed ID: 8419369 [TBL] [Abstract][Full Text] [Related]
59. Comparison of secretory expression in Escherichia coli and Streptomyces of Streptomyces subtilisin inhibitor (SSI) gene. Taguchi S; Kumagai I; Miura K Biochim Biophys Acta; 1990 Jul; 1049(3):278-85. PubMed ID: 2200522 [TBL] [Abstract][Full Text] [Related]
60. Characterization of sequences within heparin-binding EGF-like growth factor that mediate interaction with heparin. Thompson SA; Higashiyama S; Wood K; Pollitt NS; Damm D; McEnroe G; Garrick B; Ashton N; Lau K; Hancock N J Biol Chem; 1994 Jan; 269(4):2541-9. PubMed ID: 8300582 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]